The MonarchE trial: improving the clinical outcome in HR⁺ /HER2^- early breast cancer: recent results and next steps

Cancer Commun (Lond). 2023 Aug;43(8):938-942. doi: 10.1002/cac2.12466. Epub 2023 Jul 18.

Authors

François Bertucci^{1

2}, Pascal Finetti¹, Emilie Mamessier¹, Alexandre De Nonneville^{1

2}

Affiliations

¹ Laboratory of Predictive Oncology, Cancer Research Center of Marseille, Paoli-Calmettes Institute, Aix-Marseille University, INSERM UMR1068, CNRS UMR725, Team Labelled "Ligue contre le cancer", Marseille, France.
² Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor
Breast Neoplasms* / therapy
Female
Humans
Receptor, ErbB-2

Substances

Receptor, ErbB-2
Biomarkers, Tumor